Estrogen agonist and antagonist action on the human estrogen receptor in Drosophila

V G Thackray1, R H Young, J E Hooper

  • 1Program in Molecular Biology, University of Colorado Health Sciences Center, Denver 80262, USA.

Endocrinology
|October 3, 2000
PubMed

Insights

Researchers developed an estrogen-responsive system in fruit flies using human estrogen receptor alpha (ER) and a GFP reporter. This system successfully demonstrated estrogen-induced gene expression, offering a new tool for studying ER interactions.

Area of Science:

  • Molecular Biology
  • Genetics
  • Endocrinology

Background:

  • The estrogen receptor (ER) plays a crucial role in regulating gene expression across various tissues.
  • While the general mechanism of ER action is understood, specific interactions with cellular machinery remain unclear.
  • Investigating these interactions is vital for understanding ER-mediated gene regulation.

Purpose of the Study:

  • To develop a novel genetic system in Drosophila melanogaster to study estrogen receptor (ER) functional interactions.
  • To establish an estrogen-responsive reporter system in fruit flies for in vivo analysis.
  • To explore the potential of Drosophila as a model for ER research.

Main Methods:

  • Construction of transgenic fruit flies expressing human ER alpha and a green fluorescent protein (GFP) reporter gene.
  • Administration of steroidal and nonsteroidal estrogens to assess reporter gene expression in larvae.
  • Treatment with tamoxifen, an estrogen antagonist, to evaluate its effect on reporter gene induction.
  • Attempted recapitulation of ligand-independent receptor activation in vivo and in cultured Drosophila cells.

Main Results:

  • Successful development of an estrogen-responsive system in Drosophila melanogaster.
  • In vivo expression of the GFP reporter gene was observed upon exposure to estrogens.
  • Estrogen-induced reporter gene expression was effectively blocked by tamoxifen treatment.
  • Ligand-independent activation of the estrogen receptor was not observed in this system.

Conclusions:

  • The developed estrogen-responsive Drosophila system provides a powerful genetic tool for studying ER function.
  • This system can be utilized to identify and characterize the interactions between ER and cellular transcriptional machinery.
  • Further research using this model can elucidate complex ER-mediated gene regulation pathways.

Related Concept Videos

The Ratio of X Chromosome to Autosomes02:45

The Ratio of X Chromosome to Autosomes

In most organisms, sex is determined by the ratio of X and Y chromosomes. However, in some organisms, such as Drosophila and C.elegans, sex is determined by the ratio of the number of X chromosomes to the number of sets of autosomes. The Y chromosome in Drosophila is active but does not determine sex. It contains genes responsible for the production of sperms in adult flies.  
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female Drosophila...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...